市场调查报告书
商品编码
1423596
男性女乳症手术的全球市场预测(~2030 年):按手术类型、最终用户和地区进行分析Gynecomastia Procedures Market Forecasts to 2030 - Global Analysis By Procedure Type (Excision, Liposuction, Mastectomy and Minimal Incision Technique), End User and By Geography |
2023年全球男性女乳症手术市场规模为8.983亿美元,预估预测期间内复合年增长率为10.8%,至2030年达到18.417亿美元。男性女乳症或男性乳房增大可能是由荷尔蒙失衡、某些药物、肥胖或其他医疗状况引起的。
这种被称为男性女乳症手术的手术技术旨在透过去除多余的乳房组织来帮助男性获得更有男子气概、更有雕塑感的胸部外观。在进行手术之前,您应该咨询有执照的整形外科医生或其他医疗保健提供者,以确定适合您的特定情况和期望结果的最佳行动方案。
意识和接受度不断提高
随着男性女乳症变得越来越为人所知,越来越多受影响的人正在了解治疗方案。由于对男性女乳症的了解不断增加,越来越多的人寻求医疗干预来解决外观问题和相关的心理影响,因此对男性女乳症手术的需求量很大。保险公司和医疗保健系统可能会发生变化以承保男性女乳症手术。随着越来越多的人发现这些治疗方法更便宜、更容易获得,保险覆盖范围和融资选择的改善可能会推动市场成长。
手术费用高
当谈到择期手术时,患者的决定很大程度上取决于他们的支付能力。高昂的费用可能会阻碍患者接受男性女乳症手术。因此,过高的定价导致男性女乳症治疗的差异化可能会加剧健康差距。难以获得重症监护的边缘化群体和经济贫困群体可能会加剧健康差距。
医疗科技的进步
由于医疗技术的进步,新的男性女乳症治疗方法正在研究和开发。这包括超音波能量、射频辅助装置和其他最尖端科技的应用,旨在提供补充或取代传统手术技术的策略。此外,远端医疗和远距会诊使农村地区和专业医疗设施有限的地区的患者更容易获得专家意见和咨询。对于男性女乳症患者来说,这种广泛的访问可以改善获得资讯和可能的治疗方法。
文化偏见和认知
男性女乳症患者可能会推迟就医,因为担心因耻辱或文化偏见而受到评判或羞辱。延误就医可能会使病情恶化,并对人们的身心健康产生负面影响。由于缺乏对男性女乳症是一种可透过医学治癒的疾病和许多人可能不知道的合法医疗问题的认识和接受,导致报告不足和手术需求减少,从而导致市场可能会阻碍其成长。
COVID-19 的影响
许多选择性手术,包括男性女乳症治疗,在大流行最严重的时候被推迟或取消,以便将资源集中在 COVID-19 患者身上。为了节省医疗资源并降低病毒感染的风险,医院和诊所已被指示限制不必要的手术数量。全球卫生系统已经将注意力和资源从男性女乳症治疗等选择性手术上转移,以控制和遏制病毒的传播。
预计抽脂细分市场将在预测期内成为最大的细分市场
由于抽脂手术是一种常见的手术方法,用于治疗因脂肪堆积过多而导致男性乳房增大的主要原因,因此抽脂领域预计将出现良好的增长。抽脂手术是市面上流行且成功的男性女乳症手术方法,特别是在过量脂肪堆积是男性女乳症主要原因的情况下。然而,有必要咨询有执照的整形外科医生或其他医疗专业人士,根据每位患者的独特情况和期望的结果选择最佳的治疗方案。
预计整容中心细分市场在预测期内复合年增长率最高
整容手术中心根据每位客户的具体要求提供独特的手术。抽脂手术、腺体组织切除术、内视镜手术或根据患者情况组合使用多种方法。这些诊所聘请了擅长男性女乳症治疗的整形外科医生和医疗专业人员。他们确保最佳结果、病人安全并遵守专业标准。在治疗期间,我们保持谨慎和专业的环境,并注重患者的隐私和保密。
由于北美地区注重先进的医疗基础设施、严格的法规、患者安全和护理质量,并且重要公司的存在是区域扩张的驱动因素,预计北美地区将在预测期内实现增长。预计将占据最大的市场占有率。此外,由于医疗设施的便利性和可支配收入相对较高,人们可以更容易获得男性女乳症的治疗。该行业的竞争透过促进创新和确保高标准的护理来进一步巩固该地区的优势,从而推动该地区的市场成长。
预计亚太地区在预测期内的复合年增长率最高。这是因为,随着亚太地区对男性女乳症及其治疗方法的认识不断提高,与男性女乳症相关的耻辱感正在逐渐消失,导致人们对治疗的接受度更高,需求也更强烈。此外,亚太地区近年来经历了显着的经济成长,人口可支配收入的增加加速了该地区的市场扩张。
According to Stratistics MRC, the Global Gynecomastia Procedures Market is accounted for $898.3 million in 2023 and is expected to reach $1841.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Gynecomastia, or male breast enlargement, can be brought on by hormone imbalances, certain drugs, obesity, or other medical disorders. Surgical techniques known as gynecomastia operations are designed to help men achieve a more manly and sculpted chest look by removing extra breast tissue. People should speak with a licensed plastic surgeon or other healthcare provider before having any operation done in order to determine the best course of action for their particular situation and desired results.
Increasing awareness and acceptance
As gynecomastia becomes better known, more people who are impacted by it learn about their choices for treatment. As more people seek medical intervention to address their worries about appearance and the psychological effects that go along with it, there is a greater demand for gynecomastia operations as a result of this heightened knowledge. Insurance companies and healthcare systems may change to provide coverage for gynecomastia operations. A wider group of people may find these therapies more inexpensive and accessible with improved insurance coverage or financing alternatives driving the growth of the market.
High procedure costs
When it comes to elective operations, patients' decisions are heavily influenced by affordability. Exorbitant expenses may cause patients to seek fewer gynecomastia operations, which would have an impact on the market if people choose not to pursue therapy because of budgetary difficulties. Thus health disparities may be exacerbated by differences in access to gynecomastia treatments brought on by exorbitant pricing. Healthcare disparities may be exacerbated for members of marginalized or economically poor populations who may find it difficult to obtain critical treatments.
Advancements in medical technology
New gynecomastia treatment approaches are being investigated and developed as a result of ongoing breakthroughs in medical technology. This covers the application of ultrasonic energy, radiofrequency-assisted devices, and other cutting-edge technologies that seek to offer complementary or alternative strategies to conventional surgical techniques. Moreover, patients in rural locations or places with limited access to specialized healthcare facilities now have more access to expert views and consultations thanks to telemedicine and teleconsultation. For those with gynecomastia, this wider reach improves access to information and possible therapies.
Cultural stigma and perception
People who are affected with gynecomastia may put off seeking medical attention out of stigma and cultural preconceptions because they are afraid of being judged or embarrassed. Delays can make the illness worse and have an adverse effect on people's physical and emotional health. Lack of knowledge or acceptance of gynecomastia as a legitimate medical problem which is a medically curable condition that many people may be unaware of, which might result in underreporting and a decline in the demand for operations thus hamper the growth of the market.
Covid-19 Impact
In order to concentrate resources for COVID-19 patients, numerous elective operations, including gynecomastia treatments, were postponed or cancelled during the height of the pandemic. In an effort to save medical resources and lower the danger of virus transmission, hospitals and clinics were instructed to restrict the number of unnecessary procedures. Global healthcare systems directed their attention and resources away from elective surgery, such as gynecomastia treatments, in order to manage and control the virus's spread.
The liposuction segment is expected to be the largest during the forecast period
The liposuction segment is estimated to have a lucrative growth, as liposuction is a popular surgical method used to treat cases where the buildup of extra fat is the main cause of male breast enlargement. Liposuction is a popular and successful method in the market for gynecomastia procedures, particularly in situations where the buildup of extra fat is the primary cause of gynecomastia. However, in order to choose the best course of action based on each patient's unique situation and desired results, it is imperative to speak with a licensed plastic surgeon or other healthcare professional.
The cosmetic surgical centers segment is expected to have the highest CAGR during the forecast period
The cosmetic surgical centers segment is anticipated to witness the highest CAGR growth during the forecast period, Cosmetic surgery facilities provide unique operations catered to the specific requirements of each customer. These might involve liposuction, excision of glandular tissue, endoscopic procedures, or a mix of methods according to the patient's condition. Board-certified cosmetic surgeons and medical professionals skilled in gynecomastia treatments work at these clinics. They guarantee the best possible results, patient safety, and professional standards compliance. Throughout the course of therapy, they keep a discreet and professional atmosphere, placing a high value on patient privacy and confidentiality.
North America is projected to hold the largest market share during the forecast period owing to the sophisticated healthcare infrastructure, strict regulations, focus on patient safety and quality of care and presence of important companies are the drivers driving the regional expansion. Furthermore, people can seek gynecomastia therapies more easily due to the increased accessibility to healthcare facilities and comparatively larger disposable expenditures. The rivalry in this sector further solidifies the region's supremacy by fostering innovation and ensuring a high level of treatment driving the growth of the market in this region.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to rising knowledge of gynecomastia and its treatment choices is developing in the Asia Pacific area, so the stigma associated with gynecomastia is progressively disappearing, leading to more acceptability and a stronger demand for therapies. In addition, the Asia Pacific area has had notable economic expansion in recent times, which has led to a rise in the population's disposable income, hence augmenting market expansion in the area.
Key players in the market
Some of the key players profiled in the Gynecomastia Procedures Market include Sun Pharmaceuticals Industries Ltd, Cadila Pharmaceuticals Ltd, Biochem Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd, Dr. Reddy's Laboratories Ltd, Vyaire Medical, MicroAire Surgical Instruments, Bausch Health Companies, Stryker Corporation, Lumenis, Johnson & Johnson, Cutera, GALDERMA, Cynosure and AbbVie Inc.
In December 2023, AbbVie Inc. and Cerevel Therapeutics announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline
In November 2023, Johnson & Johnson MedTech1 announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).
In July 2023, Cadila Pharma launches Posaconazole for treatment of fungal diseases, The drug has also been recommended as a second line treatment for Mucormycosis or black fungus as it is commonly known.